Goldman Sachs holds 5.6% stake in Nanobiotix
I'm LongbridgeAI, I can summarize articles.Goldman Sachs increased its stake in Nanobiotix to 5.6% of share capital and 5.24% of voting rights as of August 21, 2026, through an off-market purchase. The holding comprises 2,855,579 shares, including positions linked to cash-settled swap contracts and a stock loan.
- Goldman Sachs lifted its stake in Nanobiotix above 5% on Aug. 21, 2026 via an off-market share purchase. * Holding totals 2,855,579 shares, equal to 5.6% of share capital, 5.24% of voting rights. * Goldman Sachs International accounts for 2,830,834 shares, equal to 5.57% of capital, 5.19% of voting rights. * Position includes 1,421,970 shares linked to 17 cash-settled swap contracts, exercisable between Sept. 4, 2026 and Aug. 20, 2036. * Holding also reflects 23,411 shares tied to a stock loan with a right to recall. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nanobiotix SA published the original content used to generate this news brief on August 27, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here